NeuroCytonix Board of Directors Appoints Jeff Balagna as Vice Chairman
ROCKVILLE, Md., March 24, 2022 /PRNewswire-PRWeb/ --NeuroCytonix Inc., today announced that Jeff Balagna, a Partner at Gryphon Investors, LLC, has been appointed as a Vice Chairman of their Board of Directors. As NeuroCytonix's Vice Chairman of the Board, Mr. Balagna will bring his extensive healthcare and services industries experience to assist the company as they continue to develop transformative medical biotechnology focused on tissue engineering and regeneration.
- NeuroCytonix Inc., today announced that Jeff Balagna, a Partner at Gryphon Investors, LLC, has been appointed as a Vice Chairman of their Board of Directors.
- ROCKVILLE, Md., March 24, 2022 /PRNewswire-PRWeb/ --NeuroCytonix Inc., today announced that Jeff Balagna, a Partner at Gryphon Investors, LLC, has been appointed as a Vice Chairman of their Board of Directors.
- As NeuroCytonix's Vice Chairman of the Board, Mr. Balagna will bring his extensive healthcare and services industries experience to assist the company as they continue to develop transformative medical biotechnology focused on tissue engineering and regeneration.
- "I am honored and excited to take on the role of Vice Chairman of the Board," said Mr. Balagna.